原发性高血压患者胰岛素抵抗与抗心磷脂抗体的分析

doi:10.3969/j.issn.1006-6233.2017.07.003

Abstract
Figure/Table
References
Related Citation (3)

Download: PDF (1348 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To explore the association of insulin resistance and anticardiolipin antibodies in patients with essential hypertension. Methods: 120 patients with essential hypertension in our hospital from February 2015 to February 2016 were selected as experimental group. 56 healthy subjects were selected at the same time in our hospital as the control group. The body mass index, fasting insulin and fasting blood glucose were compared between the two groups. Insulin resistance indexes were calculated in two groups. Anticardiolipin antibodies (ACA-IgG, ACA-IgM) levels of the two groups were compared. Assosiations between insulin resistance and ACA-IgG and ACA-IgM were analyzed. Results: The fasting insulin level and insulin resistance index in the experimental group were significantly higher than those in the control group (P<0.05).The serum ACA-IgG and ACA-IgM in the experimental group were significantly higher than those in the control group (P<0.05).Serum ACA-IgG level was positively correlated with insulin resistance (P<0.05), but there was no correlation between serum ACA-IgM level and insulin resistance (P>0.05). Conclusion: There's significant insulin resistance in patients with essential hypertension, and there's a positive correlation between the level of serum ACA-IgG and the level of resistance. It suggests that there is a tendency to thrombosis in patients with essential hypertension.

Key words： Essential hypertension Insulin resistance Anticardiolipin antibody

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WU Xiaomei
	ZHU Ling
	WU Linna

Cite this article:

WU Xiaomei,ZHU Ling,WU Linna. Analysis of Insulin Resistance and Anticardiolipin Antibodies in Patients with Essential Hypertension[J]. HeBei Med, 2017, 23(7): 1064-1066.

URL:

http://www.hbyxzzs.cn/EN/10.3969/j.issn.1006-6233.2017.07.003 OR http://www.hbyxzzs.cn/EN/Y2017/V23/I7/1064

[1] Rodríguez-Iturbe B,Pons H,Quiroz Y,et al.The immunological basis of hypertension[J].Am Hypertens,2014;27(11):1327~1337.
[2] Araujo M,Wilcox CS.Oxidative stress in hypertension:role of the kidney[J].Antioxid Redox Signal,2014,20(1):74~101.
[3] Visvanathan S,Scott JK,Hwang K-K,et al.Identification and characterization of a peptide mimetic that may detect a species of disease-associated anticardiolipin antibodies in patients with the antiphospholipid syndrome[J].Arthritis Rheum,2013,48(3):737~745.
[4] Yadalam PK,Rajapandian K,Ravishankar PL,et al.Evaluation of anticardiolipin antibodies in tobacco users and non-tobacco users with severe chronic periodontal disease[J].IntSocPrev Community Dent,2016,6(3):256~260.
[5] Jameil NA,Tyagi P,Shenefy AA.Incidence of anticardiolipin antibodies and lupus anticoagulant factor among women experiencing unexplained recurrent abortion and intrauterine fetal death[J].Int Clin Exp Pathol,2015,8(3):3204~3209.
[6] 聂如琼,刘家荣,邓冰清,等.胰岛素抵抗对非糖尿病急性冠状动脉综合征患者预后的影响[J].中华心血管病杂志,2013,41(7):559~562.
[7] 车晓宁,阮彩莲.不同级别高血压患者胰岛素抵抗、血清脂联素水平的相关性[J].中国老年学杂志,2016,36(3):711~712.
[8] 谢洁,蒲丹岚,张莉,等.厄贝沙坦对2型糖尿病合并高血压患者胰岛素抵抗及胰岛β细胞功能的影响[J].第三军医大学学报,2014,36(15):1635~1638.
[9] 刘华,林娜.具有原发性高血压遗传史的健康子女胰岛素抵抗及早期肾损害与遗传因素关系的研究[J].中华老年医学杂志,2015,34(6):638~640.
[10] 周少雄,谢伟贤,邓爱红,等.脑血栓形成患者抗心磷脂抗体与VWF因子抗原的关系[J].广东医学,2013,34(12):1867~1868.
[11] 徐静雯,王楠.银杏叶提取物联合奥美沙坦酯治疗原发性高血压的疗效及其对血清蛋白表达的影响[J].中国药房,2016,27(23):3257~3260.
[12] 庄献博,徐光军,王未飞,等.脑梗死患者血清抗心磷脂抗体和血管内皮生长因子水平与卒中后认知障碍的关系[J].中华行为医学与脑科学杂志,2015,24(2):152~154.
[13] 周璕,张永红,江波,等.杀伤细胞免疫球蛋白样受体基因多态性与原发性高血压关系的病例对照研究[J].中华流行病学杂志,2015,36(6):589~593.
[14] 黄汉菊,卢建雄,杨月嫦,等.缬沙坦联合氨氯地平治疗社区原发性高血压的临床疗效及安全性[J].中国老年学杂志,2013,33(9):2154~2155.
[15] 张添甜,孙光,张潇怡,等.老年原发性高血压合并2型糖尿病患者动态血压监测的临床研究[J].中国医科大学学报,2014,43(4):308~312.